Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)

Shweta Singh, E. Selvarajan, Abhi Bhadra, Shaswat Chandrakar, Vanshika Kumar, Sakshi Sankhla, Sayuj Raj T.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global epidemic statusclaiming more than 319K lives and affecting more than 4.81M people and counting worldwide.Considering the severity of the situation and low recovery rate many research institutions andpharmaceutical industries are rushing to learn more about this new virus and the morbid physiologyof this disease with effective diagnostic methods, therapeutic agents and vaccines. Various approachesare highlighted for comparing the possible treatment methods available for COVID-19 some of whichare BCG vaccination on COVID-19 and Non-pharmaceutical interventions, drug based clinical trials ofHydroxychloroquine-Azithromycin, chloroquine, lopinavir/ritonavir, ChAdOx1 nCoV-19, Remdesivir,Stem Cell therapy and mesenchymal stromal cell therapy, etc.

2020

cytokines, chloroquine, hydroxychloroquine, Stem cell therapy, Lopinavir, ritonavir, remdesivir

DOI: 10.22207/JPAM.14.SPL1.36

Journal of Pure and Applied Microbiology

Journal of Pure and Applied Microbiology

Microbiology